HIV trials in Mexico

In Mexico 13 Also abroad 789

13 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
Where
Guadajalara, Mérida, Mexico City, San Pedro Garza García
Age
12 years and over
People
564 worldwide
Run by
ViiV Healthcare
See details and how to joinNCT07650916 · EU 2024-518511-19-00
No phaseEnrolling by invitation
Effect of Omega-3 Supplementation on Pregnant Outcomes and Inflammation Markers of Women Infected With HIV Using Antiretroviral Therapy
Where
Mexico City
Age
18 years and over
People
92
Run by
Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes
See details and how to joinNCT06971445
Phase 2/3Taking people
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Where
León, Veracruz
Age
18 years and over
People
570 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07266831 · EU 2025-522519-40-00
No phaseTaking people
Paradoxical Tuberculosis Reactions in Patients Without HIV Infection
Where
Mexico City
Age
18 years to 99 years
People
140 worldwide
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT04052022
Phase 2Taking people
Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)
Where
Coyoacán, Mérida, Mexico City
Age
4 weeks to 11 years
People
84 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT04375800
Phase 4Taking people
Effectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Compared With Darunavir/Cobicistat Plus Tenofovir Alafenamide/Emtricitabine in Virologically Suppressed People Living With HIV at 24 and 48 Weeks of Follow-up
Where
Mexico City
Age
18 years and over
People
78
Run by
Instituto Mexicano del Seguro Social
See details and how to joinNCT07678268
No phaseNot yet taking people in Mexico
Coronary Artery Calcium Score in HIV Mexican Population (The CACsHIVMex Study)
Where
León
Age
18 years and over
People
384
Run by
Instituto Mexicano del Seguro Social
See details and how to joinNCT07662161
No phaseEnrolling by invitation
Short-term Steroid Therapy in Patients With P. Jirovecii Pneumonia Due to HIV / AIDS
Where
México
Age
18 years to 80 years
People
196
Run by
Centro de Investigación en. Enfermedades Infecciosas, Mexico
See details and how to joinNCT03856229
Phase 3Taking people
DOR/TDF/3TC COmpared With BIC/FTC/TAF in ART-Naïve People Living With HIV and Overweight or Obesity
Where
Mexico City
Age
18 years to 70 years
People
306
Run by
José Antonio Mata Marín
See details and how to joinNCT07075146
Phase 4Taking people
Efficacy, Safety, and ToLerability of Switching to A Two-Drug Regimen With DTG/3TC Compared to Maintaining A Three-Drug REgimen With BIC/FTC/TAF or DTG/3TC/ABC in ViroLogically SupprEssed PeopLe Living With HIV After 24 and 48 Weeks of Follow-Up
Where
Mexico City
Age
18 years to 70 years
People
156
Run by
José Antonio Mata Marín
See details and how to joinNCT07138144
Phase 4Taking people
Safety, Tolerability and Effectiveness of DTG/3TC vs BIC/TAF/FTC in PWH Without Antiretroviral Experience
Where
Mexico City
Age
18 years and over
People
124
Run by
Instituto Mexicano del Seguro Social
See details and how to joinNCT07031063
Phase 4Taking people
Effectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Versus Darunavir/Cobicistat Plus Tenofovir/Emtricitabine in Virologically Suppressed HIV-1-positive Individuals in Mexico
Where
Mexico City
Age
18 years to 70 years
People
138
Run by
José Antonio Mata Marín
See details and how to joinNCT06907056
No phaseTaking people
Caspofungin for Pneumocystis Pneumonia in PLWHIV.
Where
Mexico City
Age
18 years to 60 years
People
60
Run by
Instituto Nacional de Enfermedades Respiratorias
See details and how to joinNCT06691321